Continuous
Novel Integration of Process Analytical Technologies for Continuous Biomanufacturing
Edita Botonjic-Sehic, Ph.D.
ReciBioPharm
PAO-07-25-CL-05Aug 06, 2025
FDA
Axcynsis Therapeutics Receives FDA Clearance for IND Application of AT03-65 Powered by AxcynDOT™ Technology
Axcynsis Therapeutics
PR-01-25-NI-19Jan 16, 2025
CDMO
The Improvements of the Production and Stability of a mAb-Chelator Conjugate by Modified Transchelation Conditions
Hyung-il Lee, Ph.D.
GBI
PAO-11-24-CL-09Dec 20, 2024
ADC
Chime Biologics and Waterstone Jointly Develop and Manufacture Antibody-Drug Conjugate (ADC)
Chime Biologics
PR-10-24-NI-91Nov 12, 2024
ADC
World ADC San Diego Celebrates 15th Anniversary With Industry-Leading Agenda
World ADC
PR-10-24-NI-37Oct 10, 2024